UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity

Nature Immunology, 2005-12, Vol.6 (12), p.1245-1252

2005

Volltextzugriff (PDF)

Cytokines in multiple sclerosis: from bench to bedside

Pharmacology & therapeutics (Oxford), 2005-05, Vol.106 (2), p.163-177

2005

Volltextzugriff (PDF)

Directed Migration of Neural Stem Cells to Sites of CNS Injury by the Stromal Cell-Derived Factor 1α/CXC Chemokine Receptor 4 Pathway

Proceedings of the National Academy of Sciences - PNAS, 2004-12, Vol.101 (52), p.18117-18122

2004

Volltextzugriff (PDF)

The roles of the new negative T cell costimulatory pathways in regulating autoimmunity

Immunity (Cambridge, Mass.), 2004-05, Vol.20 (5), p.529-538

2004

Volltextzugriff (PDF)

Expression of Cux-1 and Cux-2 in the subventricular zone and upper layers II-IV of the cerebral cortex

Journal of comparative neurology (1911), 2004-11, Vol.479 (2), p.168-180

2004

Volltextzugriff (PDF)

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice

The Journal of experimental medicine, 2003-07, Vol.198 (1), p.63-69

2003

Volltextzugriff (PDF)

Serum 25-hydroxyvitamin D predicts cognitive performance in adults

Neuropsychiatric disease and treatment, 2015-01, Vol.11 (default), p.2217-2223

2015

Volltextzugriff (PDF)

Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis

The Journal of experimental medicine, 2003-07, Vol.198 (1), p.71-78

2003

Volltextzugriff (PDF)

Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex

Nature genetics, 2004-01, Vol.36 (1), p.69-76

2004

Volltextzugriff (PDF)

Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo

The Journal of experimental medicine, 1995-08, Vol.182 (2), p.357-366

1995

Volltextzugriff (PDF)

Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis

Journal of neuroimmunology, 2005-07, Vol.164 (1), p.10-21

2005

Volltextzugriff (PDF)

Identification of MS-specific serum miRNAs in an international multicenter study

Neurology : neuroimmunology & neuroinflammation, 2018-09, Vol.5 (5), p.e491-e491

2018

Volltextzugriff (PDF)

Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis

Multiple sclerosis, 2007-09, Vol.13 (8), p.1004-1010

2007

Volltextzugriff (PDF)

Predictors of treatment switching in the Big Multiple Sclerosis Data Network

Frontiers in neurology, 2023, Vol.14, p.1274194-1274194

2023

Volltextzugriff (PDF)

Regulatory functions of CD8+CD28– T cells in an autoimmune disease model

The Journal of clinical investigation, 2003-10, Vol.112 (7), p.1037-1048

2003

Volltextzugriff (PDF)

Role of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis

Journal of allergy and clinical immunology, 2003-11, Vol.112 (5), p.837-849

2003

Volltextzugriff (PDF)

Neural Stem/Progenitor Cells Express Costimulatory Molecules That Are Differentially Regulated by Inflammatory and Apoptotic Stimuli

The American journal of pathology, 2004-05, Vol.164 (5), p.1615-1625

2004

Volltextzugriff (PDF)

Increased Interleukin 12 Production in Progressive Multiple Sclerosis: Induction by Activated CD4+ T Cells via CD40 Ligand

Proceedings of the National Academy of Sciences - PNAS, 1997-01, Vol.94 (2), p.599-603

1997

Volltextzugriff (PDF)

Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy

The Journal of clinical investigation, 1998-08, Vol.102 (4), p.671-678

1998

Volltextzugriff (PDF)

Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor- beta 1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients

The Journal of clinical investigation, 1996-07, Vol.98 (1), p.70-77

1996

Volltextzugriff (PDF)

Three Cases of Herpes Zoster Radiculitis in MS Patients Treated with Natalizumab

Multiple sclerosis and related disorders, 2016-09, Vol.9, p.122-124

2016

Volltextzugriff (PDF)

Corticotropin-Releasing Hormone Contributes to the Peripheral Inflammatory Response in Experimental Autoimmune Encephalomyelitis

The Journal of immunology (1950), 2005-05, Vol.174 (9), p.5407-5413

2005

Volltextzugriff (PDF)

Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis

Archives of neurology (Chicago), 2000-08, Vol.57 (8), p.1183

2000

Volltextzugriff (PDF)

The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo

The Journal of clinical investigation, 2000-07, Vol.106 (1), p.63-72

2000

Volltextzugriff (PDF)

Daclizumab in treatment of multiple sclerosis patients

Multiple sclerosis, 2009-02, Vol.15 (2), p.272-274

2009

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(92)
Tagungsberichte
(1)

Sprache

Englisch
(93)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity

Cytokines in multiple sclerosis: from bench to bedside

Directed Migration of Neural Stem Cells to Sites of CNS Injury by the Stromal Cell-Derived Factor 1α/CXC Chemokine Receptor 4 Pathway

The roles of the new negative T cell costimulatory pathways in regulating autoimmunity

Expression of Cux-1 and Cux-2 in the subventricular zone and upper layers II-IV of the cerebral cortex

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice

Serum 25-hydroxyvitamin D predicts cognitive performance in adults

Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis

Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex

Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo

Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis

Identification of MS-specific serum miRNAs in an international multicenter study

Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis

Predictors of treatment switching in the Big Multiple Sclerosis Data Network

Regulatory functions of CD8+CD28– T cells in an autoimmune disease model

Role of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis

Neural Stem/Progenitor Cells Express Costimulatory Molecules That Are Differentially Regulated by Inflammatory and Apoptotic Stimuli

Increased Interleukin 12 Production in Progressive Multiple Sclerosis: Induction by Activated CD4+ T Cells via CD40 Ligand

Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy

Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor- beta 1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients

Three Cases of Herpes Zoster Radiculitis in MS Patients Treated with Natalizumab

Corticotropin-Releasing Hormone Contributes to the Peripheral Inflammatory Response in Experimental Autoimmune Encephalomyelitis

Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis

The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo

Daclizumab in treatment of multiple sclerosis patients

Suchergebnisse filtern